Abstract:Nuclear factor erythroid-2 related factor 2 (Nrf2) is a master transcription factor that controls the basal and inducible expression of a battery of antioxidant genes and other cytoprotective phase II detoxifying enzymes. While knockout of Nrf2 exaggerates cardiac pathological remodeling and dysfunction in diverse pathological settings, pharmacological activation of Nrf2 protects against cardiomyocyte injury and cardiac dysfunction. In contrast, there is also a concern that the chronic activation of Nrf2 secondary to oxidative stress is a contributing mechanism for the reductive stress-mediated heart failure. However, a direct link between cardiac specific activation of Nrf2 and cardiac protection or dysfunction in vivo remains to be established. Therefore, we investigated the effect of cardiomyocyte-specific transgenic activation of Nrf2 (Nrf2ctg) on cardiac pathological remodeling and dysfunction. We found that the cardiomyocyte-specific activation of Nrf2 suppressed myocardial oxidative stress as well as cardiac apoptosis, fibrosis, hypertrophy, and dysfunction in a setting of sustained pressure overload induced by transverse aortic arch constriction (TAC) in mice. Notably, the constitutive activation of Nrf2 increased the steady level of autophagosomes while decreasing the ubiquitinated protein aggregates in the heart after TAC. Nrf2 gene gain- and loss-of-function approaches revealed that Nrf2 enhances autophagosome formation and autophagic flux in cardiomyocytes. Unexpectedly, while Nrf2 minimally regulated apoptosis, it suppressed significantly the proteotoxic necrosis in cardiomyocytes. In addition, Nrf2 attenuated the proteocytotoxicity presumably via enhancing autophagy-mediated clearance of ubiquitinated protein aggregates in cardiomyocytes. Taken together, we demonstrated for the first time that cardiac specific activation of Nrf2 suppresses cardiac maladaptive remodeling and dysfunction most likely by enhancing autophagic clearance of toxic protein aggregates in the heart.

Targeting the Nrf2 Pathway Against Cardiovascular Disease

Targeting Nrf2 signaling pathway: new therapeutic strategy for cardiovascular diseases

Nrf2 at the heart of oxidative stress and cardiac protection

Nrf2 and cardiovascular defense

An overview of the mechanisms and novel roles of Nrf2 in cardiovascular diseases.

Friend or Foe: Xenobiotic Activation of Nrf2 in Disease Control and Cardioprotection

The Nrf-2/HO-1 Signaling Axis: A Ray of Hope in Cardiovascular Diseases

Nrf2-Keap1 in Cardiovascular Disease: Which is the Cart and Which the Horse?

The Role of the Nrf2/ARE Antioxidant System in Preventing Cardiovascular Diseases

Nrf2 enhances myocardial clearance of toxic ubiquitinated proteins

Nrf2 for cardiac protection: pharmacological options against oxidative stress

Induction of Cardiac Pathology: Endogenous versus Exogenous Nrf2 Upregulation

Nrf2 for a key member of redox regulation: A novel insight against myocardial ischemia and reperfusion injuries

The role of Nrf2 in carcinogenesis

Modulation of NRF2 signaling pathway by nuclear receptors: implications for cancer.

The Beneficial Role of Nrf2 in the Endothelial Dysfunction of Atherosclerosis

The role of Nrf2 in oxidative stress-induced endothelial injuries

Diabetic cardiomyopathy and its prevention by nrf2: current status.

Role of Nrf2in neuroprotection and its mechanisms

The Role of Natural Products in Targeting Cardiovascular Diseases via Nrf2 Pathway: Novel Molecular Mechanisms and Therapeutic Approaches

Nrf2 Protects Against Maladaptive Cardiac Responses to Hemodynamic Stress